CERo Therapeutics Stock (NASDAQ:CERO)
Previous Close
$1.46
52W Range
$1.33 - $376.00
50D Avg
$2.77
200D Avg
$18.52
Market Cap
$4.45M
Avg Vol (3M)
$671.34K
Beta
0.43
Div Yield
-
CERO Company Profile
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.